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TObjectives: Closure of isolated secundum atrial septal defect is generally recom-
mended at the age of 4 to 5 years. However, there are children with isolated
secundum atrial septal defect in whom early closure should be performed. We aimed
to assess the underlying conditions that led to earlier closure in this special patient
group and to analyze the outcome.
Methods and Results: From January 1990 through August 2002, 24 infants with
isolated secundum atrial septal defect underwent surgical closure within the first
year of life. All children were symptomatic. Signs of pulmonary hyperperfusion,
such as tachydyspnea, failure to thrive, recurrent respiratory infections, or heart
failure, were present. Four infants required artificial ventilation. Ten patients had
additional problems, such as prematurity with chronic lung disease, hepato-
omphalocele and congenital diaphragmatic hernia, which were present in 1 patient
each. Eleven patients had defined dysmorphic syndromes. All but 1 infant under-
went preoperative invasive hemodynamic evaluation. Thirteen patients had pulmo-
nary hypertension preoperatively. The follow-up time was 46  33 months (range,
4-125 months). At follow-up, pulmonary artery pressure proved to be normal in 11
of the 13 children who had pulmonary hypertension previously. One patient died of
persistent pulmonary hypertension. Clinical performance, growth, and development
improved in nearly all patients. All ventilator-dependent children could be weaned
shortly after atrial septal defect closure.
Conclusions: If lungs are compromised, even a minor left-to-right shunt might be
poorly tolerated in infancy. In these children early surgical closure of an isolated
secundum atrial septal defect should be performed to support thrive and growth and
to prevent the onset of irreversible changes of the pulmonary vasculature.
Atrial septal defect (ASD) is a common congenital heart defect with anincidence of 7%.1 Atrial left-to-right shunting is well tolerated inotherwise healthy children, and the majority of patients with isolated
secundum atrial septal defect (ASD II) remain asymptomatic in infancy and
childhood. Usually there is neither pulmonary hypertension nor an increase of
pulmonary vascular resistance (PVR) at that age. Typically, closure of isolated
ASD II is undertaken in the fourth or fifth year of life, preferably through
interventional device closure.2 However, there is a group of patients who
undergo ASD closure much earlier in life. These patients present with severe
problems during infancy, such as recurrent respiratory infections, failure to
thrive, heart failure, and respiratory insufficiency necessitating artificial venti-
lation. This study was initiated to describe the conditions that led to the decision
of early closure and to determine whether these conditions were resolved by
means of closure of the defect. Because device closure in the first year of life is
not feasible, early closure refers to surgical intervention.
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DIf ASD II remains untreated, pulmonary hypertension
can be expected in one third of the patients in the third
decade and in two thirds in the fourth decade of life.3-5
Other late problems of untreated ASD II are atrial dysrhyth-
mia and heart failure. Overall, it is estimated that in the
natural history of ASD, half of the patients who survived the
first year of life will reach 37 years of age.5
Patients and Methods
Patients
We retrospectively reviewed the records of all 24 patients who
underwent surgical closure of isolated ASD II within the first year
of life from January 1990 through August 2002 in our hospital.
The mean age at closure was 6.7 2.9 months (range, 1.3-11.6
months). There were 17 girls and 7 boys. The mean weight at the
time of surgical intervention was 5.2  1.6 kg (range, 2.5-8.9 kg).
TABLE 1. Patients’ characteristics at the time of surgical
No. Extracardiac diagnosis-problems Age (mo)
1 — 3.8
2 26 WGA, hydrocephalus, psychomotor
retardation
7.3
3 Median cleft syndrome 8.9
4 Trisomy 21, immunodeficiency syndrome 6.3
5 Noonan syndrome, congenital
diaphragmatic hernia
6.9
6 32 WGA, CHARGE syndrome 11.6
7 Trisomy 21, lung sequester 9.7
8 Laryngomalacia, stenosis of left main
bronchus (70%)
8.4
9 Atrial tachycardia, microcephalus,
amaurosis
10.6
10 — 6.1
11 25 WGA 4.0
12 36 WGA, arthrogryposis multiplex congenita 4.9
13 Hallermann-Streiff syndrome 8.2
14 Noonan syndrome, psychomotor retardation 11.3
15 36 WGA, hepato-omphalocele 4.4
16 — 2.5
17 34 WGA, umbilical hernia 6.7
18 32 WGA, VACTERL association,
tracheomalacia
4.4
19 SGA 8.6
20 33 WGA, asphyxia palladia 9.2
21 Cleft palate, Pierre-Robin syndrome 1.3
22 35 WGA, trisomy 21 2.4
23 SGA 4.6
24 31 WGA 10.5
Mean  SD 6.4  3.3
Range 6.6
PAP, Pulmonary artery pressure; PAP/AoP, systolic pulmonary pressure/s
pulmonary resistance; WGA, weeks of gestational age; CHARGE, colobom
and/or central nervous system anomalies, genital hypoplasia, and ear anom
abnormalities, tracheoesophageal fistula and/or esophageal atresia, renaBefore surgical intervention, all patients were symptomatic, show-
1354 The Journal of Thoracic and Cardiovascular Surgery ● Juning signs of tachydyspnea and heart failure. Thirteen patients were
long-standing hospital inpatients before they were scheduled for
surgical ASD II closure. Four patients were dependent on artificial
ventilation and could not be weaned preoperatively. Children who
were admitted for surgical intervention had recurrent respiratory
infections, which frequently led to intermittent hospitalization.
Specific problems of the patients are outlined in Table 1.
Preoperatively, all but 1 infant underwent cardiac catheteriza-
tion and angiography. The results showed that 13 patients had
pulmonary hypertension, which was defined as a mean pulmonary
artery pressure of greater than 25 mm Hg. Eight of these infants
had an increased PVR calculated from the mean pressure gradient
over the pulmonary vascular bed and pulmonary blood flow values
obtained from oximetry by using the Fick principle. The PVR was
moderately increased (3-5 units · m2) in 5 patients and severely
increased (5 units · m2) in 3 patients. In these 3 patients the PVR
vention
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Mean PAP
(mm Hg) PAP/AoP
Qp/Qs
(L · min1 · m2)
Rp
(E · m2)
.8 16 0.33 3.00 1.5
.1 24 0.46 1.38 3.6
.8 27 0.45 1.70 3.4
.8 64 0.88 1.17 11.6
.7 40 0.67 1.91 4.5
.2 26 0.54 2.50 1.9
.4 43 0.67 3.95 1.2
.9 17 0.33 2.60 1.4
.0 48 0.57 2.10 1.4
.8 48 0.68 2.67 4.0
.5 — — — —
.3 18 0.38 2.00 2.0
.9 33 0.67 1.64 4.2
.2 33 0.60 1.60 3.7
.7 45 1.00 1.25 9.3
.7 48 0.86 1.75 8.7
.7 26 0.40 1.60 1.8
.2 19 0.48 3.33 0.8
.2 18 0.51 2.36 1.2
.1 12 0.22 1.07 1.6
.4 31 0.84 28.2 0.4
.6 24 0.75 9.00 0.5
.5 15 0.46 4.00 0.9
.3 16 0.46 1.86 1.7
1.6 30.0  13.6 0.6  0.2 3.7  5.6 3.1  2.9
.8 26 0.5 2 1.8
aortic pressure; Qp, pulmonary blood flow; Qs, systemic blood flow; Rp,
art disease, atresia choanae, retarded growth and retarded development
and/or deafness; VACTERL, vertebral abnormalities, anal atresia, cardiac
esis and dysplasia, and limb defects; SGA, small for gestational age.inter
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Dof 1.0. In patient 4, who died 6 months after surgical intervention,
the PVR decreased from 11.6 to 3.8 units · m2 with a fraction of
inspired oxygen of 1.0. In patients 15 and 16 PVR decreased from
9.3 to 3.2 units · m2 and from 8.7 to 3.2 units · m2, respectively.
The mean left-to-right shunt, also calculated on the basis of oxim-
etry, was 52%. A right-to-left shunt was found in 10 infants, and
the mean right-to-left shunt was 3.9%. In one of these patients a
preoperative arterial oxygen saturation of 85% in room air was
measured, but at cardiac catheterization, even this patient showed
increased pulmonary blood flow. None of the other patients were
cyanotic at rest.
Follow-up Investigations
All children participated in a follow-up investigation. All patient
histories were taken with special emphasis on the children’s ability
to thrive and on general psychomotor development. They had
complete physical examinations, electrocardiography, and chest
radiography. Pulmonary artery pressure was evaluated noninva-
sively by means of echocardiography in all children. Because none
of the patients had right ventricular outflow obstruction or pulmo-
nary stenosis, the systolic pulmonary artery pressure was estimated
from the peak flow velocity in the tricuspid regurgitation jet by
using the modified Bernoulli equation. In patients without tricuspid
regurgitation, the right ventricular pressure was assumed to be
normal if the following echocardiographic criteria were present: no
right ventricular hypertrophy or dilatation, no ventricular septal
deviation, and normal pulmonary artery flow profile.
Statistics
All descriptive data are shown as means SD (range). Weight and
length were considered to be normally distributed. Z-scores of
weight and length were calculated as follows: Z-score  (Mea-
sured value – Reference mean)/Reference SD.
Reference values were taken from Centers for Disease Control
and Prevention growth charts.6 For the premature infants, age was
corrected according to prematurity. We did not use any specific
percentiles for infants with trisomy or for twins. A 2-tailed paired
t test was performed to compare data before surgical intervention
with data from follow-up.
The clinical condition of the patients was defined as a treatment
score as follows:
1. At home without anticongestive medication
2. At home with anticongestive medication
3. Hospitalized with medication and breathing spontaneously
4. Hospitalized with mechanical ventilation
5. Dead
A 2-tailed Wilcoxon test was performed to compare the treat-
ment score before surgical intervention with the score at follow-up.
Results
Surgical Strategy and Perioperative Mortality
In 4 patients the ASD was closed with direct sutures, and in
20 patients a patch closure was performed. There was no
perioperative mortality.
The Journal of ThoracicFollow-up
The mean follow-up period was 49  33 months (range,
4-125 months). One patient died 6 months after surgical
intervention. In this patient persistent pulmonary hyperten-
sion was diagnosed at follow-up 4 months after surgical
intervention. Absolute weight (5.2  1.7 kg before surgical
intervention vs 16.2  9.1 kg after surgical intervention, n
 20, P .0005) and length (60.9 7.6 cm before surgical
intervention vs 100.7  22.0 cm after surgical intervention,
n 20, P .0005) increased postoperatively. The increases
in z scores, representing the catch-up growth, were not
significant (weight/z: 2.6  2.2 before vs 2.0  2.6
after, n 20, P .30; length/z:1.8 1.8 before vs1.2
 2.2 after, n  20, P  .27). Nevertheless, in 14 patients
a positive percentile change regarding weight and in 12
patients a positive percentile change regarding length was
documented.
Clinical Condition
All children with feeding problems gained strength, started
oral feeding (even those with feeding tubes), and thrived.
All patients were weaned from the ventilator shortly after
surgical intervention, even those patients who could not be
weaned preoperatively (patients 2, 6, 11, and 15). In partic-
ular, those children who were physically handicapped im-
proved. In those children, indispensable physiotherapy, or-
thopedic treatment, or elective orthopedic surgery, which
had previously been postponed because of a poor clinical
situation, could be performed after ASD II closure.
Our self-defined treatment score also showed a signifi-
cant improvement (P  .005, Figure 1). Nevertheless, there
was one girl (patient 22) with trisomy 21 in whom persistent
pulmonary hypertension was suspected on the basis of echo-
cardiography 6 months after surgical intervention. She re-
ceives oxygen therapy at home and is scheduled for diag-
Figure 1. Self-defined treatment scores.nostic cardiac catheterization.
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DDiscussion
This study shows that ASD closure can be performed safely
without perioperative mortality in infants, even in the pres-
ence of severe comorbidity. Most patients showed a good
functional outcome at follow-up. In general, ASD II with
associated pulmonary hypertension and increased PVR is a
rare finding in infancy and not solely a result of atrial
left-to-right shunting. This suggests other substrates for the
presence of pulmonary hypertension. In our study group, for
example, diaphragmatic hernia with prenatal mechanical
compression of the lungs led to pulmonary hypoplasia. In
other infants chronic lung disease caused by prematurity
was the reason for reduction of the total pulmonary vascular
diameter. This condition might explain our hemodynamic
findings of pulmonary hypertension. If other noncardiac
malformations are present, it is impossible to determine the
effect of left-to right shunting on growth and clinical symp-
toms. Increased pulmonary blood flow might further en-
hance the pulmonary vascular remodeling already induced
by other factors and thus affect the clinical condition
substantially.
Bull and colleagues7 suggested, in a similar patient
group, that pulmonary vascular obstructive disease might be
the primary abnormality in these patients, with the ASD
being an incidental, although exacerbating, finding. Also,
other small published series showed that children with ASD
II presenting in infancy with clinical symptoms are very
heterogeneous regarding associated problems. Mainwaring
and associates8 reviewed 6 symptomatic infants with iso-
lated ASD who underwent early surgical closure. They
report that 5 of 6 children demonstrated little or no improve-
ment in symptoms and point out the frequent noncardiac
basis of failure to thrive with an associated ASD in this
patient group. Andrews and coworkers,9 who presented 6
patients after closure of symptomatic ASD in infancy,
pointed out the need to search carefully for other underlying
cardiac or pulmonary abnormalities. If other causes for
pulmonary hypertension are excluded, they recommend clo-
sure of the ASD, although they emphasize that clinical
symptoms might persist if other pathology is present.
Careful assessment of cardiac morphology is necessary
to exclude left-sided obstructive cardiac malformations and
additional shunts that might contribute to pulmonary hyper-
tension. Regarding our patients with adverse outcomes (pa-
tient 4, who died, and patient 22, in whom pulmonary
hypertension developed after ASD closure), it is remarkable
that both patients are infants with Down syndrome. It is well
known that these patients, even in the absence of structural
heart disease, are at risk for development of persistent
pulmonary hypertension.10 Histologic investigations sug-
gest that the smaller number of alveoli and the smaller
alveolar surface area accompanied by a loss of capillary
surface area is responsible for the aggravation of pulmonary
1356 The Journal of Thoracic and Cardiovascular Surgery ● Junhypertension in this patient group.11 Looking retrospec-
tively at the hemodynamic catheter data, patient 4 had a
severely increased PVR (11.6 E · m2), although responding
to oxygen with a significant decrease in PVR. The other 2
patients (patients 15 and 16, both without Down syndrome)
with markedly increased PVR are doing well postopera-
tively, without any sign of persistent pulmonary hyper-
tension.
Patient 22 had no pulmonary hypertension preopera-
tively, and pulmonary hypertension was found at follow-up
after ASD closure. It cannot be excluded that irreversible
pulmonary vascular disease preexisted because of pulmo-
nary hyperperfusion, which did not cause an increased PVR
at the time of cardiac catheterization. In contrast, there is
one patient with trisomy 21 in our patient group who is
doing well after closure.
On the basis of the catheter data, there is no reliable
marker that indicates whether closure of the ASD is safe.
Therefore particularly in patients with Down syndrome, the
indication for early ASD closure needs to be evaluated
carefully.
Perhaps these patients should be considered for ASD
closure with a fenestrated patch, subsequent close follow-
up, and liberal use of vasodilation therapy.
The practical approach during the preoperative catheter-
ization should include assessment of PVR and, if necessary,
responsiveness to oxygen and nitric oxide. If a marked
increase in pulmonary artery pressure, pulmonary artery
resistance, or both without a response to oxygen and nitric
oxide is noticed, ASD closure should not be performed.
Also, if diminished pulmonary blood flow with cyanosis is
present, the ASD should not be closed.
Left-to-right shunt, in addition to any pulmonary com-
promising factors, might accelerate and even enhance the
progress of pulmonary vascular disease. In contrast to the
majority of these lung diseases, such as dysplasia, the ASD
is a problem that can be approached. For the majority of
children, ASD closure in infancy has been beneficial; how-
ever, frequent clinical follow-up is essential to identify
those patients who require additional therapy. Patients with
preoperative pulmonary hypertension and those with signs
of pulmonary hypertension after surgical intervention need
repeated catheterization. Again, PVR studies are required to
determine responsiveness to vasodilator therapy.
The natural history of these children is unknown, assess-
ment is controversial, and often the decision for early clo-
sure of the ASD has been the result of an individual eval-
uation after long-standing intensive care treatment and
exhaustion of conservative medical management. Although
older reports12-15 focus on the postponement of surgical
intervention, today the surgical risk is not a limiting factor.
Regarding even major operations with cardiopulmonary by-
pass in infants with low weight, mortality has become low
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Dwith increasing expertise over the last 20 years.16-18 Today,
surgical intervention can be performed with a low risk, as
we showed in our patient group of multihandicapped chil-
dren with no perioperative mortality. It has been reported
that interventional ASD closure is an option, even in small
children. However, the vascular complication rate, ratio of
device diameter to atrial septal diameter, loss of atrial mo-
tility, and atrioventricular valve dysfunction remain a prob-
lem. Therefore, we do not generally recommend an inter-
ventional approach in infancy.
After ASD closure, other clinical problems could be
addressed. Physiotherapy or orthopedic treatment were fa-
cilitated after surgical intervention and led to a better clin-
ical condition of these infants. Early closure of the ASD II
seems to enhance the feeding situation and clinical perfor-
mance and might also support better growth in these chil-
dren. A special benefit was achieved in those children, who
were dependant on artificial ventilation preoperatively, in
whom weaning was successful shortly after surgical inter-
vention.
Limitations of the Study
This is a retrospective study. Our patient group is very
heterogeneous, which made it difficult to establish an ap-
propriate control group because the majority of infants had
syndromes or severe associated malformations that also
have an effect on long-term survival and quality of life.
Also, a randomized approach cannot be justified on obvious
ethical grounds.
The use of normal percentiles for growth is disputable.
Many of the syndromes are associated with syndrome-
related growth retardation at different ages. However, per-
centile curves for these syndromes do not exist. Therefore
even our finding that no catch-up growth is reached post-
operatively can be misleading.
Conclusions
Closure of an ASD should not be postponed to a later age if
clinical problems that can be attributed at least in part to the
ASD are present. In the majority of patients, the PVR will
return to normal after ASD closure, and the clinical condi-
tion will improve.
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